PMDA device listing

ルミパルスプレスト βHCG

PMDA In vitro diagnostic listing · 21400AMZ00570000 · Class I

Key facts

PMDA document key 670773_21400AMZ00570000_A_28
Brand names ルミパルスプレスト βHCG
General names (JMDN) 血液検査用ヒト絨毛性性腺刺激ホルモンキット
Product type In vitro diagnostic
Device class (Japan) Class I
Approval, certification or notification number 21400AMZ00570000
JMDN codes 30332001
Category code A0100
Marketing authorization holder 製造販売/富士レビオ株式会社
Package insert date Jul 1, 2022
Latest revision 2022-07
PMDA product page pmda.go.jp
Package insert on pmda.go.jp pmda.go.jp

At a glance

  • 1–9 Package insert revisions
  • None Related PMDA documents
  • Listed Listed on the PMDA site
  • No Refers to a technical manual

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA medical device and IVD listings (Japan)

Medical devices and in vitro diagnostics sold in Japan are approved by the MHLW, certified by a registered certification body or notified, depending on class, and the PMDA publishes each product's package insert. Only identifiers, names and dates are shown here; package insert text and review reports are not reproduced.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, medical device package insert database · Source date:

Browse all PMDA medical device and IVD listings (Japan)